The analyses by Matsubara et al. at the >50% threshold are consistent with our observation that PD-L2 abundance exceeded PD-L1 in 15 of 20 NSCLC in the subcohort we analyzed. This evidence concerns the gene PDCD1LG2 and non-small cell lung carcinoma.